4-arylamino-quinazolines as activators of caspases and inducers of apoptosis

Details for Australian Patent Application No. 2004253967 (hide)

International Classifications

Event Publications

2 February 2006 PCT application entered the National Phase

PCT publication WO2005/003100 Priority application(s): WO2005/003100

4 February 2010 Amendment Made

The nature of the amendment is: Amend the name of the co-inventor from Jaing, Songchun to Jiang, Songchun

4 February 2010 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Myriad Genetics, Inc. Application No. 2004253967, under INID (71) add the co-applicant Cytovia, Inc.

18 February 2010 Application Accepted

Published as AU-B-2004253967

24 June 2010 Amendment Made

The nature of the amendment is: Amend the co-inventor name from Jaing, Songchun to Jiang, Songchun

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.